Cardinal Health, Inc. reported impairment charges for the third quarter ended March 31, 2024. for the quarter, the company reported pre-tax goodwill impairment charge of $90 million related to the GMPD segment.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.46 USD | -0.63% | +0.43% | -2.32% |
May. 17 | JPMorgan Adjusts Cardinal Health Price Target to $111 From $119 | MT |
May. 15 | Argus Adjusts Price Target on Cardinal Health to $115 From $120 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.32% | 23.98B | |
+21.82% | 73.31B | |
+4.89% | 8.8B | |
+10.52% | 8.6B | |
-19.56% | 8.07B | |
+14.65% | 5.26B | |
-0.93% | 4.16B | |
+12.13% | 4.14B | |
-2.41% | 3.88B | |
+24.77% | 3.72B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024